Status:
UNKNOWN
Pityriasis Lichenoides Chronica, Role of Streptococcal Infection and Azithromycin
Lead Sponsor:
Cairo University
Conditions:
Pityriasis Lichenoides
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
Primary outcome: The primary outcome at end of study (EOS) is to compare the therapeutic efficacy of Azithromycin in the treatment of pityriasis lichenoides chronica (PLC) with that of a well-documen...
Eligibility Criteria
Inclusion
- Patients with classic papular eruption of PLC (scaly erythematous papules with mica-like scales) with diagnosis documented histopathologically with or without associated hypopigmented lesions
- Age: \> 6 years
- Both sexes.
Exclusion
- Patients presenting with only hypopigmented macules whom their skin biopsy revealed PLC.
- Patients with hypopigmented lesions that reveal mycosis fungoides pathologically.
- Patients with PLC associated with classic MF.
- Patients with known absolute contraindications to NB-UVB.
- Patients with impaired liver and/or kidney functions.
- Patients with history of any heart disease.
- Patients with known hypersensitivity to Azithromycin
- \-
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03831269
Start Date
February 1 2019
End Date
August 1 2020
Last Update
February 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Alainy Faculty of Medicine Cairo University
Cairo, Egypt